MedTrace Logo

Resveratrol and Vascular Function in CKD

NCT03597568 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2024-11-01

Study results available
· View outcomes & findings →

Summary

The proposed research is clinical study evaluating the therapeutic benefits of resveratrol on vascular function in patients with chronic kidney disease (CKD). The study aims to establish that resveratrol will improve endothelial function and functional performance by reducing oxidative stress and in conjunction with lowering markers of inflammation and oxidative stress.

Conditions

  • Chronic Kidney Diseases
  • Endothelial Dysfunction

Interventions

DIETARY_SUPPLEMENT

Resveratrol

Oral supplementation for 6 weeks

OTHER

Placebo

Oral supplementation for 6 weeks

Sponsors & Collaborators

  • Diana Jalal

    lead OTHER

Principal Investigators

  • Diana Jalal · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2023-01-12
Completion
2023-01-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03597568 on ClinicalTrials.gov